Copperwynd Financial LLC trimmed its stake in UnitedHealth Group Inc (NYSE:UNH) by 75.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,477 shares of the healthcare conglomerate’s stock after selling 4,577 shares during the period. Copperwynd Financial LLC’s holdings in UnitedHealth Group were worth $368,000 at the end of the most recent reporting period.
Other hedge funds have also modified their holdings of the company. LSV Asset Management increased its stake in shares of UnitedHealth Group by 14.0% in the third quarter. LSV Asset Management now owns 46,050 shares of the healthcare conglomerate’s stock valued at $12,251,000 after buying an additional 5,650 shares in the last quarter. Keel Point LLC acquired a new stake in shares of UnitedHealth Group in the third quarter valued at $238,000. Toronto Dominion Bank increased its stake in shares of UnitedHealth Group by 6.8% in the third quarter. Toronto Dominion Bank now owns 677,549 shares of the healthcare conglomerate’s stock valued at $180,217,000 after buying an additional 43,367 shares in the last quarter. Edgestream Partners L.P. increased its stake in shares of UnitedHealth Group by 59.9% in the third quarter. Edgestream Partners L.P. now owns 11,605 shares of the healthcare conglomerate’s stock valued at $3,087,000 after buying an additional 4,346 shares in the last quarter. Finally, Dakota Wealth Management increased its stake in shares of UnitedHealth Group by 14.7% in the third quarter. Dakota Wealth Management now owns 6,977 shares of the healthcare conglomerate’s stock valued at $1,856,000 after buying an additional 893 shares in the last quarter. Institutional investors and hedge funds own 85.61% of the company’s stock.
Shares of UNH stock opened at $252.02 on Friday. The company has a debt-to-equity ratio of 0.64, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a market capitalization of $246.73 billion, a P/E ratio of 19.57, a PEG ratio of 1.32 and a beta of 0.79. UnitedHealth Group Inc has a 12 month low of $212.49 and a 12 month high of $287.94.
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 1.43%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 27.95%.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 2,930 shares of the firm’s stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $253.39, for a total transaction of $742,432.70. Following the transaction, the director now owns 64,726 shares in the company, valued at $16,400,921.14. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Richard T. Burke sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $245.01, for a total value of $1,225,050.00. Following the transaction, the director now owns 182,372 shares in the company, valued at approximately $44,682,963.72. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 32,930 shares of company stock worth $8,495,383. Company insiders own 0.87% of the company’s stock.
A number of analysts have recently weighed in on UNH shares. Cleveland Research restated a “buy” rating on shares of UnitedHealth Group in a research note on Friday, January 11th. Credit Suisse Group restated a “buy” rating and issued a $310.00 target price on shares of UnitedHealth Group in a research note on Friday, February 8th. Argus raised their target price on UnitedHealth Group from $285.00 to $295.00 and gave the company a “buy” rating in a research note on Monday, December 17th. Stephens started coverage on UnitedHealth Group in a research note on Monday, January 14th. They issued an “overweight” rating and a $287.00 target price for the company. Finally, Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday. Three research analysts have rated the stock with a hold rating and twenty have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $297.80.
TRADEMARK VIOLATION NOTICE: This news story was published by Ticker Report and is the property of of Ticker Report. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.tickerreport.com/banking-finance/4239716/copperwynd-financial-llc-has-368000-stake-in-unitedhealth-group-inc-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Why is the price-sales ratio important?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.